{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:03:28Z","timestamp":1788545008158,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.vaccine.2019.03.031","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T10:24:12Z","timestamp":1553509452000},"page":"2340-2347","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells"],"prefix":"10.1016","volume":"37","author":[{"given":"Yuhua","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzhi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5260-7128","authenticated-orcid":false,"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.03.031_b0005","unstructured":"WHO. Global eradication of poliomyelitis by the year 2000. World Health Assembly. Genevea 1988 (Resolution NO. 141128)."},{"key":"10.1016\/j.vaccine.2019.03.031_b0010","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","article-title":"Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication","volume":"27","author":"Minor","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.03.031_b0015","first-page":"795","article-title":"Picornaviridae: The virus and their replication","author":"Racaniello","year":"2007","journal-title":"Fields Virol"},{"key":"10.1016\/j.vaccine.2019.03.031_b0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(88)90172-9","article-title":"Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor","volume":"166","author":"Ypma-Wong","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.03.031_b0025","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1128\/jvi.66.7.4597-4600.1992","article-title":"Molecular basis of antigenic structures of poliovirus: Implications for their evolution during morphogenesis","volume":"66","author":"Wiegers","year":"1992","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.03.031_b0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/viro.1993.1044","article-title":"Antigenic sites on type 2 poliovirus","volume":"192","author":"Patel","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.03.031_b0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2471\/BLT.06.038414","article-title":"Human papillomavirus and HPV vaccines: a review","volume":"85","author":"Cutts","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2019.03.031_b0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1586\/14760584.6.3.381","article-title":"Virus-like particles: Flexible platforms for vaccine development","volume":"6","author":"Chackerian","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2019.03.031_b0045","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1016\/j.vaccine.2007.02.059","article-title":"Evaluation of influenza virus-like particles and Novasome adjuvant as candidate vaccine for avian influenza","volume":"25","author":"Pushko","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.03.031_b0050","doi-asserted-by":"crossref","first-page":"e1006117","DOI":"10.1371\/journal.ppat.1006117","article-title":"Genetically thermo-stabilised, immunogenic poliovirus empty capsids; a strategy for nonreplicating vaccines","volume":"13","author":"Fox","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2019.03.031_b0055","doi-asserted-by":"crossref","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.03.031_b0060","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/j.1460-2075.1994.tb06337.x","article-title":"Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein","volume":"13","author":"Ryan","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2019.03.031_b0065","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.addr.2014.10.023","article-title":"Formulation and stabilization of recombinant protein based virus-like particle vaccines","volume":"93","author":"Jain","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2019.03.031_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/491021a","article-title":"Hepatitis E vaccine debuts","volume":"491","author":"Bin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.03.031_b0075","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1099\/0022-1317-70-6-1453","article-title":"Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector","volume":"70","author":"Urakawa","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.03.031_b0080","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1006\/viro.1993.1067","article-title":"Formation of poliovirus-like particles by recombinant baculovirus expressing the individual VP0, VP3 and VP1 proteins by comparison to particles derived from the expressed poliovirus polyprotein","volume":"192","author":"Br\u00e4utigam","year":"1993","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.03.031_b0085","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/jvi.65.4.2088-2092.1991","article-title":"Coinfection with recombinant vaccinia viruses expressing poliovirus P1 and P3 proteins results in polyprotein processing and formation of empty capsid structures","volume":"65","author":"David","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2019.03.031_b0090","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1099\/0022-1317-78-8-1829","article-title":"Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae","volume":"78","author":"Rombaut","year":"1997","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2019.03.031_b0095","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/viro.1999.0043","article-title":"Poliovirus protease 3C(pro) kills cells by apoptosis","volume":"266","author":"Barco","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.03.031_b0100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s10529-010-0295-8","article-title":"Formation of virus-like particles from O-type foot-and-mouth disease virus in insect cells using codon-optimized synthetic genes","volume":"32","author":"Yimei Cao","year":"2010","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.vaccine.2019.03.031_b0105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41467-017-00090-w","article-title":"Plant-made polio type 3 stabilized VLPs-a candidate synthetic polio vaccine","volume":"8","author":"Marsian","year":"2017","journal-title":"Nat Commun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19303536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:50Z","timestamp":1759401110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19303536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0264410X19303536"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.031","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like particle vaccines for poliovirus types 1, 2, and 3 with enhanced thermostability expressed in insect cells","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}